Cargando…
Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods coul...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450593/ https://www.ncbi.nlm.nih.gov/pubmed/31001458 http://dx.doi.org/10.7759/cureus.4004 |
_version_ | 1783409046569615360 |
---|---|
author | Shaabanpour Aghamaleki, Fateme Mollashahi, Behrouz Nosrati, Mokhtar Moradi, Afshin Sheikhpour, Mojgan Movafagh, Abolfazl |
author_facet | Shaabanpour Aghamaleki, Fateme Mollashahi, Behrouz Nosrati, Mokhtar Moradi, Afshin Sheikhpour, Mojgan Movafagh, Abolfazl |
author_sort | Shaabanpour Aghamaleki, Fateme |
collection | PubMed |
description | Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome. |
format | Online Article Text |
id | pubmed-6450593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-64505932019-04-18 Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia Shaabanpour Aghamaleki, Fateme Mollashahi, Behrouz Nosrati, Mokhtar Moradi, Afshin Sheikhpour, Mojgan Movafagh, Abolfazl Cureus Genetics Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome. Cureus 2019-02-04 /pmc/articles/PMC6450593/ /pubmed/31001458 http://dx.doi.org/10.7759/cureus.4004 Text en Copyright © 2019, Shaabanpour Aghamaleki et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Genetics Shaabanpour Aghamaleki, Fateme Mollashahi, Behrouz Nosrati, Mokhtar Moradi, Afshin Sheikhpour, Mojgan Movafagh, Abolfazl Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title | Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title_full | Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title_fullStr | Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title_full_unstemmed | Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title_short | Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia |
title_sort | application of an artificial neural network in the diagnosis of chronic lymphocytic leukemia |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450593/ https://www.ncbi.nlm.nih.gov/pubmed/31001458 http://dx.doi.org/10.7759/cureus.4004 |
work_keys_str_mv | AT shaabanpouraghamalekifateme applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia AT mollashahibehrouz applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia AT nosratimokhtar applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia AT moradiafshin applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia AT sheikhpourmojgan applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia AT movafaghabolfazl applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia |